Shareholder Rebellion Intensifies at Tiptree Over Fortegra Sale

A significant investor has launched a forceful campaign against Tiptree’s proposed divestiture of its insurance subsidiary, Fortegra. Veradace Partners, the second-largest independent shareholder with a 5 percent stake, has declared it will vote against the sale to DB Insurance, a transaction valued at approximately $1.65 billion. The announcement of the deal has already triggered a substantial 23 percent decline in Tiptree’s share value.

The financial markets have expressed deep skepticism through a sharp sell-off. Tiptree shares recently traded at $18.39, reflecting the 23 percent drop since the Fortegra deal was made public. This significant gap between the current market capitalization and the transaction’s value points to profound concerns about corporate strategy and potential Read more...